Andrew J Wicks

Years Active: 2020-2022
Publications (10 Years): 5

Institute of Cancer Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Cancer Research Apr 03 2018

United Kingdom

Scientific Officer :: Breast Cancer Research

Publications

Andrew J Wicks, Dragomir B Krastev, Stephen J Pettitt, Andrew N J Tutt, Christopher J Lord
Opinion: PARP inhibitors in cancer-what do we still need to know? Open biology 12 (7) (2022)
Dragomir B Krastev, Shudong Li, Yilun Sun, Andrew J Wicks, Gwendoline Hoslett, Daniel Weekes, Luned M Badder, Eleanor G Knight, Rebecca Marlow, Mercedes Calvo Pardo, Lu Yu, Tanaji T Talele, Jiri Bartek, Jyoti Sharma Choudhary, Yves Pommier, Stephen J Pettitt, Andrew N J Tutt, Kristijan Ramadan, Christopher J Lord
The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. Nature cell biology 24 (1) (2022)
Dragomir B Krastev, Andrew J Wicks, Christopher J Lord
PARP Inhibitors - Trapped in a Toxic Love Affair. Cancer research 81 (22) (2021)
Ilirjana Bajrami, Callum Walker, Dragomir B Krastev, Daniel Weekes, Feifei Song, Andrew J Wicks, John Alexander, Syed Haider, Rachel Brough, Stephen J Pettitt, Andrew N J Tutt, Christopher J Lord
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency. Communications biology 4 (1) (2021)
Levani Zandarashvili, Marie-France Langelier, Uday Kiran Velagapudi, Mark A Hancock, Jamin D Steffen, Ramya Billur, Zain M Hannan, Andrew J Wicks, Dragomir B Krastev, Stephen J Pettitt, Christopher J Lord, Tanaji T Talele, John M Pascal, Ben E Black
Structural basis for allosteric PARP-1 retention on DNA breaks. Science (New York, N.Y.) 368 (6486) (2020)

Andrew J Wicks.css-eqlu8i{font-size:small;padding-left:4px;}